Procter & GamblePGTOP PICKJul 31, 2017Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
If you have strong fundamentals, technicals and seasonality, that is a good thing. There is an activist investor trying to take a seat on the board, and is pushing the company to move from 145 lines down to about 70 products. They are responding. They’ve cut costs dramatically. That is a good thing from a fundamental perspective. Seasonally, this is a good company to be in. Seasonality lasts until about mid October. It’s a place to hide. Dividend yield of 3.06%. (Analysts’ price target is $91.)